CareDx, Inc. CDNA faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions platform positions it for long-term opportunity in an $8 billion market.On Monday, William Blair initiated coverage on CareDx Inc., citing that the company is turning the page on a tumultuous recent chapter.Analyst Andrew F. Brackmann said the company is “getting back to consistency and predictability, and leaving behin ...

Uber CEO on Tesla Robotaxi“They could be a competitor, or could be a partner. When you’re talking about Trillion Dollar Total addressable markets, there will be no winner take all in this marketplace.It’s great to see Tesla in the market. They’re taking their time and making sure they’re expanding in a safe way” ...